Teladoc Health Inc Stock Price, News & Analysis

Teladoc Health (TDOC) will announce its fourth-quarter and full-year 2020 financial results on February 24, 2021, after market close. A conference call will follow at 4:30 p.m. E.T. for a detailed review of the results. Participants can join by phone or via a live audio webcast. Teladoc Health is recognized as a leader in whole-person virtual care, leveraging over a decade of insights and expertise to improve healthcare outcomes. For more details, visit the official website.

Teladoc Health released its inaugural Corporate Social Responsibility (CSR) Report, emphasizing its commitment to equitable healthcare access, responsibility, and community impact. In 2020, Teladoc provided over 10 million virtual visits, assisting over 2 million members in underserved areas. The report outlines efforts to enhance healthcare capacity during COVID-19, reduce CO₂ emissions by 5,000 metric tons per million virtual visits, and promote a diverse workplace. Additionally, the company contributed $700,000 to global health initiatives.

Teladoc Health and DexCom announced a partnership to enhance diabetes management for Type 2 diabetes patients. Joint members of Livongo for Diabetes will receive new CGM-powered insights that integrate Dexcom’s continuous glucose monitoring data with additional health signals from Teladoc. This offering aims to empower users with actionable health recommendations and will be piloted at no cost to eligible members in 2021. The collaboration highlights a rising trend in diabetes, with estimates suggesting 463 million adults currently affected globally.

Teladoc Health, the leader in virtual care, announced participation in the 39th Annual J.P. Morgan Healthcare Conference by CEO Jason Gorevic and CFO Mala Murthy on January 11, 2021, at 10:00 a.m. ET. The event will include a live audio webcast accessible on the company's investor relations page. Teladoc Health focuses on enhancing healthcare experiences with a commitment to comprehensive virtual care, leveraging a decade of expertise to improve health outcomes. The company was recognized as Best in KLAS for Virtual Care Platforms in 2020.

World Telehealth Initiative (WTI) announced a new investment from Intel aimed at expanding healthcare access in developing communities through Teladoc Health's virtual care platform. Founded in 2017, WTI currently serves over 15 communities and plans to expand to 40 within two years. This investment will enable WTI to partner with more clinics, enhancing telehealth services during the COVID-19 pandemic. The initiative addresses the critical lack of healthcare services, with more than one billion people globally unable to access necessary health services.

Teladoc Health (NYSE: TDOC) announced its participation in two prominent investor conferences. The 29th Annual Credit Suisse Annual Healthcare Conference is scheduled for November 11 at 2:45 p.m. ET, and the 32nd Annual Piper Sandler Annual Healthcare Conference will take place on December 1 at 9:00 a.m. ET. A live audio webcast will be available for both events on their investor relations page. Teladoc Health continues to lead in virtual care, enhancing healthcare experiences globally.

Teladoc Health has finalized its merger with Livongo, creating a dominant force in whole-person virtual care. This strategic combination allows the company to offer comprehensive health solutions, serving consumers and healthcare providers through advanced analytics and technology. CEO Jason Gorevic emphasized the merger's potential to enhance health outcomes. Livongo shareholders will receive 0.5920x shares of Teladoc and $11.33 cash per share. The merger was completed in under three months, following the announcement on August 5.

Teladoc Health (TDOC) received overwhelming approval from shareholders for its merger with Livongo (LVGO), with over 99% voting in favor of the charter amendment and share issuance. This decision, confirmed during a Special Meeting, paves the way for Teladoc to enhance its virtual healthcare capabilities. The merger aims to integrate data insights and personalized support for improved health outcomes. Teladoc’s CEO expressed enthusiasm over this transformative opportunity and its potential to deliver whole-person health.

Teladoc Health reported impressive financial results for Q3 2020, with revenue surging 109% year-over-year to $288.8 million, and total visits increasing 206% to 2.8 million. For the first nine months, revenue grew 79% to $710.6 million. The company raised its full-year guidance, expecting total revenue of $1,005 million to $1,015 million. Despite a net loss of $(35.9) million, excluding merger-related costs, adjusted EBITDA reached $39.5 million. Strong growth in memberships and partnerships with firms like Johns Hopkins bolster future prospects.